Performance Work Statement.docx

DOCX document 44 KB Posted

Attached to
Q515--STAT Referral Laboratory Testing
Solicitation number
36C26324Q0592
Issued by

About this file

This document is a Performance Work Statement (PWS) for a federal contract to provide highly specialized diagnostic laboratory testing and consultation services to the Minneapolis VA Health Care System (MVAHCS).

The PWS outlines the scope of work, contract type and term, and statement of work. The MVAHCS requires a contractor to provide testing services not performed in-house, such as STAT and urgent drug levels, cryoglobulin testing, HLA typing, coagulation testing, anatomic pathology and neuropathology consultations, PCR and viral culturing, and other specialized testing on various clinical specimens. The contractor's laboratory must be located within 20 miles of the MVAHCS and provide 24/7 STAT courier service. The contract is a 5-year indefinite delivery, indefinite quantity (IDIQ) commercial services contract with specific turnaround time requirements for STAT, urgent, and routine tests. The PWS includes a detailed schedule of the estimated annual quantities for each test. Contractor qualifications, quality control, reporting, and other requirements are also specified.

View the file

Other files

File Type Posted
36C26324Q0592.docx DOCX document

On GovTribe

Work with this file

  • Download the original file
  • Contacts named in this file
  • Similar government files
  • Ask GovTribe AI about this file

Text version

1. Scope of Work The Minneapolis VA Health Care System Pathology and Laboratory Medicine Service located at One Veterans Drive, Minneapolis, MN 55417, hereinafter referred to as MVAHCS, is in need of a contract to support highly specialized STAT referral laboratory testing and consultation services. All services provided shall be in accordance with the costs, terms, and conditions of this contract.

2. Contract Type and Term The MVAHCS will award a 5-year firm, fixed-price, indefinite delivery indefinite quantity commercial services contract for all items listed in the Schedule of Items. Contract use will be limited to the MVAHCS. The Periods of Performance will be:

· Ordering Period 1: 9/1/24-8/31/25

· Ordering Period 2: 9/1/25-8/31/26

· Ordering Period 3: 9/1/26-8/31/27

· Ordering Period 4: 9/1/27-8/31/28

· Ordering Period 5: 9/1/28-8/31/29

3. Statement of Work The MVAHCS requires the services of a contractor to provide highly specialized and specific diagnostic testing needs. Testing needs may consist of but are not limited to STAT and Urgent drug levels, quantitative cryoglobulin levels with identification, HLA typing, special coagulation testing, factor assays, consultation on complex anatomic pathology cases, gross and microscopic neuropathology evaluations, PCR and viral culturing of infectious agents, and enzyme immunoassay on blood, bone marrow, tissue, body fluids, swabs, and other clinical specimens. These services are not performed at the MVAHCS.

The laboratory must be able to determine levels of the following on a STAT basis:

· Amikacin

· Methotrexate

· Tobramycin

· Beta-2-transferrin

· Ketone Beta hydroxybutyrate

· Osmolality (serum & urine)

The laboratory must be able to determine levels of the following on an Urgent basis:

· Cyclosporine (by HPLC)

· Sirolimus (by HPLC)

· Tacrolimus (by HPLC)

· Everolimus

Contractor’s laboratory shall:

A. Be located within 20 miles of the MVAHCS.

B. Provide services Monday through Sunday, 24 hours a day.

C. Provide the following for transport of specimens:

· Lab test requisition forms (vendor may need to customize forms to include information required by the MVAHCS)

· Special instructions for handling of specimen.

· Specimen collection supplies for specialized testing.

D. Provide the courier service for transport of specimens.

· STAT courier service must be available 24/7, including weekends and Federal holidays. MVAHCS will request services as needed, and pickup is expected to be within 45 minutes of request.

· Routine courier service must include two daily pickups Mon-Fri, then one daily pickup Saturday, Sunday, and Federal Holidays. Morning and afternoon pickup times are preferred.

E. Submit the billing invoice monthly, following the month in which the service was delivered F. Consult with MVAHCS laboratory personnel on test results as needed.

G. Provide the MVAHCS with a means of communication to permit immediate inquiry regarding the status of a pending test.

H. Provide a Laboratory User’s Manual or similar documentation. The manual shall include a list of all tests that the Contractor can provide along with the testing methodology used for each test, test reference ranges, length of time of testing, which days the test is run, specimen requirements and any special handling required.

4. Schedule of Items:

Listed below are estimated annual quantities. The MVAHCS attempts to be as accurate as possible when providing estimated annual quantities, however, actual quantities required may vary from the quantities listed below.

Test Name
CPT
QTY
Acanthamoeba smear/sp stain
87207
1
Activated Protein C Resistance
85307
2
Additional laboratory tests not yet developed or listed in Schedule of Items
TBD
1
AFB Stain
87206
2
Amikacin
80150
37
Anaerobic ID1
87076
1
Bacterial ID (each organism)
87077
69
Beta-2 Glycoprotein 1, IgA
86146
1
Beta-2 Glycoprotein 1, IgG
86146
1
Beta-2 Glycoprotein 1, IgM
86146
1
Beta-2 Transferrin
86334
11
Bethesda Assay for Factor 8
85335
1
Bethesda Assay for Factor 9
85335
1
Bordetella pertussis & paratussis by PCR
87798
5
Cardiolipin Antibodies IgG
86147
1
Cardiolipin Antibodies IgM
86147
1
Cardiolipin Antibody, IgA
86147
1
Chlamydia/Gonorrhea by PCR
87491
4
Chlamydia/Gonorrhea by PCR
87591
4
Citric Acid, 24-hour urine
82507
360
CMV DNA, Quant by PCR
87497
565
Collagen VII Antibodies IgG
83516
10
Complement Activity Total CH50
86162
57
Concentration any type infect agent
87015
2
CRE Culture
87081
7
Cryoglobulin Identification
86334
141
Cryoglobulin, Quantitative
82595
284
Culture Bact Anaerobic
87075
1
Culture Cath tip anaerobic, foreign body
87075
1
Culture CSF Anaerobic
87075
1
Cyclosporine
80158
340
Cytomegalovirus Qual PCR
87496
14
D Dimer, Quantitative
85379
1
Dibucaine Number
82638
10
Electron Microscopy Kidney
88348
1
Enterovirus by PCR on CSF
87498
3
Epstein Barr Virus Qual PCR
87798
3
Epstein-Barr Virus PCR non blood
87799
15
Everolimus
80169
10
Factor 10 Chromogenic
85260
151
Fat Feces, Qualitative Random
82705
20
Fat Feces, Quantitative Timed
82710
8
Fibrinogen, Activity
85384
1
FISH INTERPHASE PROBE
88271
2
FISH Interphase Interp
88275
2
Fungal ID
87107
2
Fungal Susceptibility Test (MIC)
87186
1
Gram Stain
87205
1
Granulocyte Colony Stimulating Factor
83520
6
Granulocyte Macrophage CS Factor
83520
6
Hemoglobin, Plasma
83051
7
HLA ABC DR NGS
81378
59
HLA Class II NGS
81382
295
HPV High Risk and Low Risk Types DNA Tissue or Anal
87624
8
HPV High Risk Types DNA Cervical
87624
150
HSV 1/2 , Qualitative DNA by PCR, Plasma, Bronch Wash
87529
510
HSV 1/2 by PCR Swab
87529
166
IHC/CYTOCHEM stain TC
88342
21
IHC/ICC Technical Component
88341
45
Immunofluorescent stain Addl Kidney
88350
5
Immunofluorescent stain kidney
88346
1
Immunohistochem/immunocytochem PF
88341
45
INR Protime
85610
19
INTERLEUKIN 6
83529
27
Ketone Beta-Hydroxybutyrate Quantitative, Rapid
82010
31
Macroglobulins
85810
10
Malaria Screen, Rapid, Emergency
87899
2
Meningitis Encephalitis Panel
87483
41
Methotrexate
80204
137
MGMT Promoter Methylation testing
81287
3
Microsporidium Stain
87207
4
Morphometric Analysis nerve kdy
88356
1
Mycobact culture isolate
87116
2
Neuropathology Autopsies
N/A
15
Non-organism stain Pro Fee
88313
1
Non-organism stain TC
88313
1
Occult Blood Gastric
82771
6
Organism Stain TC
88312
2
Osmo, Serum
83930
10
Osmo, Stool
83935
1
Osmo, Urine
83935
3
Oxalic Acid, 24-hour urine
83945
360
Parasite Culture
87081
2
PARASITE STAIN
87207
5
PARASITES THICK PREP
87015
6
Path block consult Hemepath PF
88323
1
Path block consult Pro Fee
88323
12
Path block consult TC
88323
12
Path block consult, Hemepath TC
88323
1
Path Consultation Slide Review
88321
7
Phenobarbital
80184
9
Plasminogen Chromogenic
85420
1
Platelet Function Closure Time, Collagen/ADP
85576
47
Platelet Function Closure Time, Collagen/Epi
85576
37
Platelet Function P2Y12 (Verify Now)
85576
11
Porphobilinogen Deaminase, RBC
82657
6
Primidone
80188
15
Primidone and Metabolite/Phenobarbital
80184
3
Pseudocholinesterase Total (with Dibucaine)
82480
10
PTT, Activated
85730
2
Rapamycin (Sirolimus)
80195
172
Review outside slides Pro Fee
88321
5
Sensitivities, MIC
87186
31
Special stain for organism Pro Fee
88312
2
Specific Antibiotic Sens Panel
87181
50
Sulfonylurea Screen
80299
11
Surg Path Level IV Kidney
88305
1
Surg Path Level IV TC EM lab
88314
1
Susceptibility Fungus by Broth
87186
16
Synovasure
83516
30
Synovasure CRP
86140
30
Tacrolimus (FK-506) (Prograff)
80197
3269
Tobramycin
80200
7
Ureaplasma species by PCR
87798
2
Urogenital Ureaplasma and Mycoplasma Species by PCR
87563
4
Varicella Zoster Virus by PCR-Qualitative
87798
130
Viral Culture - Non-Respiratory
87252
271
Viral Culture - Respiratory
87252
138
Yeast ID1
87106
33

5. Licensing and Accreditation The Contractor shall assure compliance of all procedures and practices by the following accrediting agencies, and the facility and employees shall have all licenses, permits, accreditation, professional certifications and qualifications required by federal and state law to provide laboratory testing and consult services. This includes:

A. Accreditation by College of American Pathologists (CAP) B. Accreditation by Clinical Laboratory Improvement Amendment (CLIA)

6. Contractor Qualification Requirements A. The pathologists for interpretive reports and/ or on-site consultation must have an unrestricted license to practice medicine in one of the states or territories of the United States of District of Columbia.

B. The pathologist(s) providing neuropathology consultation must be board-certified in neuropathology. It is desired the pathologist(s) have at least 5 years of experience in neuropathology.

C. Consultant anatomic pathologists must have national reputations in their areas of specialization, as evidenced by ongoing publication in academic journals and/ or presentations at national pathology meetings. Special attention will be paid to expertise in transplant and gynecologic pathology.

D. The qualifications of such personnel shall also be subject to review by MVAHCS Medical Center Laboratory Director. MVAHCS reserves the right to approve the assignment of individual personnel furnished by the Contractor to perform the functions specified in the contract.

7. Test Sample Preparation The MVAHCS shall be responsible for providing laboratory specimens prepared in accordance with the contractor’s Laboratory User’s Manual. All specimens will be properly identified and labeled for testing. The contractor’s laboratory shall have the following information available: current test menu with reference ranges, specimen requirements, and special instructions, if any. Paper requisition forms shall be available if requested.

8. Transport of Specimens Turnaround times are the utmost importance for these testing needs. The MVAHCS requires a laboratory to be local to meet STAT turn around requirements. The contractor’s laboratory is required to be within 20 miles of the MVAHCS. STAT courier service is required to be included for no additional charge and must be available 24/7, including weekends and Federal holidays. MVAHCS will request services as needed, and pickup is expected to be within 45 minutes of request. Routine courier service is required to be included for no additional charge and must include two daily pickups Mon-Fri, then one daily pickup Saturday, Sunday, and Federal Holidays. Morning and afternoon pickup times are preferred.

9. Acceptable Turn Around Times It is essential that turnaround times for test reporting be adequate to meet the patient care needs of MVAHCS. Contractors who can meet or exceed these requirements will be rated more favorably.

A. STAT: Results reported within 3 hours of specimen receipt.

· Tests that fall under this category: Amikacin, Methotrexate, Tobramycin, Beta-2-transferrin, Ketone Beta hydroxybutyrate and Osmolality (serum & urine) B. Urgent: Results reported within 24 hours of specimen receipt.

· Tests that fall under this category: Cyclosporine, Sirolimus, Tacrolimus and Everolimus.

C. Special:

· Quantitative Cryoglobulin levels with identification are to be reported within 7 days of specimen receipt.

· Final surgical pathology consultation reports are to be completed within 4 working days of specimen receipt for cases not requiring additional studies.

D. Routine: To be performed as part of regular testing procedures

· All tests not specified above fall into this category.

10. Reporting of Test Results A report is defined as a printed final copy of pathology interpretive consult. Consult reports shall be sent by contractor to a secured MVAHCS Laboratory FAX # 612-467- 5945. If results are telephoned prior to sending, the written report must include the name of the individual notified of the results, date and time of telephone report. Each consult report shall at a minimum indicate the following information:

A. Patient’s name and identification code B. Physician’s name (if supplied) C. VA Medical Center name D. Patient’s location, e.g. clinic, ward (if supplied) E. Test ordered F. Date/time of specimen collection G. Date/time specimen received in Reference Lab H. Date test completed I. Test result J. Flag abnormal results K. Reference Range L. Toxic and/or therapeutic range where applicable M. Name of testing laboratory (contractor and/or subcontractor) N. Testing laboratory specimen number O. Type of specimen P. Comments related to the test provided by the submitting lab Q. Information that may indicate a questionable validity of test results R. Unsatisfactory specimen shall be reported with reason as to its unsuitability for testing

If the vendor has a web-based portal for ordering and sending results, this can only be utilized by MVAHCS if the ISO (Informational Security Officers) find the web portal to be acceptable for use by MVAHCS. If the ISOs determine the portal is not acceptable, no additional charges will be incurred to the government for the use of FAX and paper copies for ordering and receiving test results.

11. Quality Control To ensure proper handling and test performance, the contractor shall provide the following updated information upon request during the life of the contract:

A. For quality purposes, tests routinely performed in duplicate should be indicated.

B. Coefficient of variation of quality control samples of all tests or specified tests the laboratory performs.

C. Proficiency testing data shall include a list of tests outside of the ± 2 SD range for the past two years. Contractor shall notify the laboratory of any test falling outside ± 2 SD range during the contract period.

D. Contractor shall provide address of processing sites under contract, including subcontracted testing location sites.

E. The contractor(s) facilities, methodologies (defined as the principal of the method and references), and quality control procedures may be examined by representatives of the VA at any time during the life of the contract.

F. Contractor agrees to maintain the minimum acceptable service, reporting systems and quality controls as specified herein. Immediate (within 24 hours) notification must be given to VA upon adverse action by a regulatory agency.

12. Testing Summaries Contractor shall provide the MVAHCS with a testing summary report as requested. At the end of each contract year, a cumulative (year-to-date) report shall be submitted to the MVAHCS providing the name of test ordered, price of test, cumulative totals and a total of all funds spent by the MVAHCS on laboratory testing services.

13. Testing or Contract Changes The Contractor shall advise the MVAHCS of any changes in assay methodology, procedures, reference ranges and any new tests introduced. If the contractor changes the assay procedures or a critically important component of an assay (e.g., an antibody, purified antigen, etc.) the contractor shall notify the VA Contracting Office and the MVAHCS prior to the intended change. Documentation shall be provided that the quality and efficacy of the test will remain unchanged or be improved. Changes that have not been reviewed and pre-approved by MVAHCS and mutually agreed upon in writing between the contractor and the VA Contracting Officer, may be sufficient cause for the MVAHCS to use an alternate contractor for that specific test for the duration of the contract.

The MVAHCS may require a test not listed in the Schedule of Items but is available from the contractor’s Laboratory User’s Manual. In this event, MVAHCS will send it out under the contract using the open market list price and apply it towards the Misc Line Item. MVAHCS will track usage and submit annual requests to VA contracting to update the Schedule of Items via a contract modification. These tests will be considered part of the overall contract value and together with the other tests cannot exceed the total estimated contract value.

Changes in the terms and conditions of this contract may be made only by written agreement of both parties. Contractor must submit requests for changes in writing to the VA Contracting Office. All modifications to this contract must be approved and prepared by the VA Contracting Officer for signature.

14. Contractor Telephone Numbers Contractor shall provide telephone number(s) and contact person(s) to be used by the MVAHCS for specimen inquiries, and Lab Technical/Pathologist consultation. There must be someone available at the number(s) always provided including weekends and holidays.

Phone Number Specimen Inquiries: __________________________
Lab Technical Director/Pathologists: __________________________

15. Subcontracting Approval If Contractor intends to use a subcontractor to provide any of the testing required under this contract, Contractor shall be responsible for finding a subcontractor laboratory with appropriate licensure and accreditation. Contractor shall notify the VA Contracting Office of any plan to use a subcontractor or make a subcontractor change, and request a prior acceptance and approval from VA.

Contractor will use the following subcontractor(s):
___________________________________________
___________________________________________

16. Quality Assurance The government will evaluate the Contractor’s performance under this contract and the Contractor performance will be monitored to determine if it meets the contract standards. A variety of methods may be used. Nonperformance or substandard task performance will be documented if and when it occurs. The Technical Representative will follow the methods of surveillance specified in the Performance Measures.

17. Government Roles and Responsibilities

The MVAHCS shall designate a Technical Representative to coordinate and monitor thework to be completed under this contract. Rachel Pike, Laboratory Contract Liaison hasbeen designated as the representative to coordinate these services. Her contactinformation is listed below.
Technical Representative:
Rachel Pike, MLS (ASCP)
Laboratory Contract Liaison / Lead Medical Technologist
Minneapolis VA Health Care System
One Veterans Drive
Minneapolis, MN 55417
612-467-5989
Rachel.pike@va.gov

18. Performance Measures The following performance measures will be regularly tracked and monitored throughout the effective period of this contract by the Technical Representative and reported to the Contracting Officer. Acceptable performance on these measures, along with other factors, will be primary indices of contractor performance and a key consideration in contract renewal decisions. Performance will be monitored using the following criteria:

Action/Test/Report
Turnaround time (TAT)
Acceptable Performance

STAT test for drug levels (Amikacin, Tobramycin, Methotrexate, Beta-2-Transferrin, Ketone Beta Hydroxybutyrate and Osmolality (serum & urine))

Within 3 hours of specimen receipt.
80% of all stat tests submitted

Urgent drug levels (Cyclosporine, Sirolimus, Tacrolimus and Everolimus)

Within 24 hours of specimen receipt.
80% of all urgent tests submitted

Quantitative Cryoglobulin levels with identification

Within 7 days of specimen receipt
80% of all tests submitted
Final surgical pathology consultation report completion
Within 4 working days of specimen receipt for cases not requiring additional studies
80% of all consults submitted

19. Ordering Procedures This contract does not obligate any funding; therefore, the Contractor shall provide services under this contract only as directed in task orders. Task orders for bulk dollar amounts will be issued during the contract period. Any warranted VA Contracting Officer is authorized to issue task orders under this contract. The Minneapolis laboratory personnel may place verbal orders with the contractor to meet their testing needs, up to the bulk task order total. The contractor will be required to inform the VA contract specialist or contracting officer when each task order reaches 80% of the total bulk dollar amount.

In accordance with FAR 16.505, each task order will include the following: (i) Date of order (ii) Contract number and order number (iii) Contract item number and description, quantity, and unit price or estimated cost or fee (iv) Delivery or performance date (v) Place of delivery or performance (including consignee) (vi) Packaging, packing, and shipping instructions, if any (vii) Accounting and appropriation data (viii) Method of payment and payment office, if not specified in the contract (ix) Any other pertinent information.

Invoices shall be sent to:

Department of Veterans Affairs

Financial Services Center
P O Box 149971
Austin TX 78714-9971
Customer Service Phone: 877-353-9791

Contractor must furnish a designated point of contact for placing orders. Orders for laboratory testing services shall be sent to Contractor through the contact person listed below at the following address:

(Offeror to complete)

Vendor’s Contact Person: ____________________
Telephone Number: _______________
FAX Number: ______________
Address: _____________________
____________________

20. Safety and Security Requirements Contractor will adhere to the applicable provisions of Public Law 104-191, Health Insurance Portability and Accountability Act (HIPAA) of 1996 and the National Standards to Protect the Privacy and Security of Protected Health Information (PHI). As required by HIPAA, the Department of Health and Human Services (HHS) has promulgated rules governing the security, use and disclosure of protected health information by covered entities, including the Department of Veterans Affairs (VA). As defined in the Health Insurance Portability and Accountability Act (HIPAA) Public Law 104-191, your company may be required to execute a Business Associate Agreement.

File details come from the government source that posted it. Updated .